The Technocrats Plasma Systems IPO has drawn strong interest from investors on Day 3. The total issue subscription has reached 5.6 times, while the retail portion has seen a sharp rise of 249%. The strong response has put the SME IPO under close market watch as investors assess its prospects before the issue close.
The IPO opened on August 14, 2026, and will close on August 18, 2026. The company plans to raise about ₹60.98 crore through the issue. The IPO has a price band of ₹125 to ₹132 per share and will debut on the BSE SME platform.
The demand data looks positive at first glance. Yet, a high subscription level alone does not make an IPO a safe choice. Investors also need to study the company’s financial results, valuation, business size, SME status and possible post-IPO risks.
What is the Technocrats Plasma Systems IPO?
Technocrats Plasma Systems is a small and medium enterprise, or SME, company. Its IPO is a 100% fresh issue, with no offer for sale. The draft prospectus says the issue consists of up to 46,20,000 equity shares. The face value of each share is ₹10.
The company has set the IPO price band at ₹125 to ₹132 per share. At the upper price of ₹132, the minimum retail application requires 2,000 shares, which means an investment of ₹2.64 lakh.
This is an important point for small investors. A ₹2.64 lakh minimum application is much higher than the amount seen in most mainboard IPOs. It also means that investors must have a higher risk capacity before they consider this issue.
The retail quota stands at 35%, while 50% is reserved for QIB investors and 15% for NII investors. The allotment date is expected on August 19, while refunds and credit to demat accounts are due on August 20. The BSE SME debut is scheduled for August 21, 2026.
Day 3 subscription sends a strong signal
The biggest talking point on Day 3 is the sharp rise in demand. The total subscription has reached 5.6 times, while the retail response has surged 249%. This shows that individual investors have taken a keen interest in the issue.
Such demand can create a positive mood before the close of an IPO. It can also raise expectations about the stock’s debut price. However, subscription figures do not guarantee a profit after the shares enter the market.
The company is also an SME stock. SME shares can have lower liquidity than large mainboard companies. This means an investor may not always find a buyer at the desired price. The gap between demand and actual market liquidity is therefore important.
Financial results look strong
The company’s financial numbers are one of the main positives in this IPO.
Technocrats Plasma Systems reported revenue of ₹131.41 crore in FY26, compared with ₹49.44 crore in FY25. This is a major rise in one year.
Profit after tax also rose from ₹8.11 crore in FY25 to ₹14.94 crore in FY26. The rise in profit shows that the company did not depend only on higher sales. It also reported a strong profit position during the year.
The company’s reported ROE was 56.1%, while ROCE stood at 48.55%. Its debt-to-equity ratio was 0.38. These figures suggest a business with strong returns on capital and a relatively moderate debt position.
For investors who focus on growth and profitability, these numbers are a clear positive. Still, past financial performance cannot assure future results.
What does the valuation say?
At the upper IPO price of ₹132, the company is valued on the basis of an EPS of about ₹11.63. This gives the issue a price-to-earnings ratio of roughly 11.35 times.
That valuation does not look extreme when viewed only against the reported earnings. The company also has high ROE and ROCE, which can support the case for a reasonable valuation.
But the size of the business matters. Technocrats Plasma Systems is an SME company, and its future performance can be more sensitive to changes in orders, costs, customers and market conditions.
Investors should therefore avoid a simple comparison between its P/E ratio and that of larger listed companies. A smaller company can carry a different risk profile even when its valuation looks attractive.
GMP adds to investor interest
The grey market has also added to the attention around the IPO. Technocrats Plasma Systems IPO GMP reached a reported high of ₹32 on August 17, after a low of ₹18 on August 13.
At a GMP of ₹32, the implied price would be around ₹164, based on the upper IPO price of ₹132. That suggests a possible premium of about 24.2% over the upper price band.
However, GMP is not an official market price. It is based on informal market activity and can change quickly. Investors should not use GMP alone as a reason to apply for an IPO.
A strong grey market premium can fall before the actual debut. It can also fail to translate into the same gain once the shares enter the exchange.
What analysts say about the IPO
The current IPO review from IPOWatch is “Neutral.” This is an important view because the company has strong financial growth, but the IPO also carries several risks.
The neutral view suggests that investors should look beyond the headline subscription numbers. The financial results are attractive, but the SME nature of the company and the high minimum application amount raise the level of risk.
The company’s own draft prospectus also gives a clear warning. It states that there was no formal market for the shares before this public issue. It also says that the IPO price should not be treated as a guide to the future market price after the shares enter the exchange.
That warning is especially relevant for investors who hope for a quick debut gain.
What are the main risks?
The first major risk is the high minimum application size. An investor needs ₹2.64 lakh for one retail lot at the upper price band. This is a large amount for many individual investors.
The second risk comes from the SME market itself. SME shares can have lower trading volumes than large listed stocks. This can make exit harder during weak market phases.
The third risk is the company’s small scale. Its FY26 revenue of ₹131.41 crore is far below that of large listed industrial firms. A major change in orders or costs can have a bigger effect on a small business.
The fourth risk is the uncertainty around the post-IPO share price. The company’s prospectus makes it clear that there is no assurance of an active or sustained market for its shares after the IPO.
Should investors apply?
Technocrats Plasma Systems has several positive points. Its revenue rose from ₹49.44 crore to ₹131.41 crore, while profit increased from ₹8.11 crore to ₹14.94 crore. ROE of 56.1% and ROCE of 48.55% also show strong reported returns.
The IPO has also received solid demand, with total subscription at 5.6 times and retail demand up 249% by Day 3. The reported GMP of ₹32 adds further market interest.
At the same time, investors must remember that this is an SME IPO with a ₹2.64 lakh minimum application. The stock may also face liquidity limits after the debut.
For an investor who understands SME risks and can hold the shares for the long term, the company’s financial growth may make the IPO worth a closer look. For a conservative investor, the risk level may be too high.
Final verdict
The Technocrats Plasma Systems IPO presents a mixed picture, but the positive side is quite clear. Strong revenue growth, higher profit, high return ratios and solid IPO demand give the company a strong case.
The risk side is also clear. The ₹60.98 crore issue is an SME IPO, the minimum application is ₹2.64 lakh, and post-IPO liquidity and price movement remain uncertain.
The current Neutral analyst view appears reasonable. The IPO may suit investors who can accept higher risk and have a long-term view. It may not suit those who want a low-risk IPO or a guaranteed debut gain.
The IPO closes on August 18, 2026. Allotment is due on August 19, and the BSE SME debut is scheduled for August 21.
Ultimately, the 5.6x subscription figure and 249% retail jump are signs of strong demand, not proof of future returns. Investors should make the final decision after they assess their own risk level, investment size and ability to hold an SME stock through periods of low liquidity.
ALSO READ: Sunshine Pictures IPO: Zero Bids? Full Analyst View
